EnWave présente ses résultats financiers intermédiaires consolidés pour le troisième trimestre 2024
Delta, BC, August 23, 2024
EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today reported the Company’s consolidated interim financial results for the third quarter ended June 30th, 2024, demonstrating strong improvement over the first and second quarters this fiscal year.
Toutes les valeurs sont exprimées en milliers et en dollars canadiens, sauf indication contraire.
- Reported revenue for Q3 2024 of $2,622 compared to $2,486 for Q3 2023, representing an increase of $136. The increase was related to a large-scale machine resale with a higher margin and increased small scale machines sales for the period.
- Reported royalty revenues of $425, representing an increase of $31 relative to the comparable period in the prior year due to increased sales and production from current royalty partners.
- Reported an Adjusted EBITDA(1) (refer to NON-IFRS Financial Measures section below) profit of $85 for Q3 2024, compared to an Adjusted EBITDA(1) loss of $192 in the same period in the prior year due to the resale of a high margin large-scale machine and increased royalty revenues.
- Gross margin for the three months ended Q3 2024 was 44% compared to 29% for the three months ended Q3 2023. The increase in margin was a result of the resale of the large-scale machine with a higher margin and increased royalties.
- Reported Selling, General & Administrative (“SG&A”) costs (including Research & Development (“R&D”) of $1,364 which increased by $178 from the comparable period in the prior year due to increased personnel costs, legal fees and increased sales efforts, including higher attendance at trade shows.
Performance financière consolidée :
($ ‘000s) | Three months ended June 30, | Nine months ended June 30, | |||||
2024 | 2023 | Change % | 2024 | 2023 | Change % | ||
Revenues | 2,622 | 2,486 | 5% | 4,547 | 9,906 | (54%) | |
Direct costs | (1,471) | (1,767) | (17%) | (3,330) | (5,894) | (44%) | |
Gross margin | 1,151 | 719 | 60% | 1,217 | 4,012 | (70%) | |
Operating expenses | |||||||
General and administration | 664 | 501 | 33% | 1,740 | 1,753 | (1%) | |
Sales and marketing | 358 | 277 | 29% | 1,149 | 1,167 | (2%) | |
Research and development | 342 | 408 | (16%) | 1,127 | 1,220 | (8%) | |
1,364 | 1,186 | 15% | 4,016 | 4,140 | (3%) | ||
Net loss – continuous operations | (235) | (918) | 74% | (2,938) | (974) | 206% | |
Net loss – discontinued operations | (32) | (1,031) | 97% | (35) | (5,703) | 99% | |
Adjusted EBITDA(1) income (loss) | 85 | (192) | 144% | (1,939) | 703 | (376%) | |
Loss per share: | |||||||
Continuous operations – basic and diluted | $ 0.00 | $ (0.01) | $ (0.02) | $ (0.01) | |||
Discontinued operations – basic and diluted | $ 0.00 | $ (0.01) | $ 0.00 | $ (0.05) | |||
Basic and diluted | $ 0.00 | $ (0.02) | $ (0.02) | $ (0.06) |
Note:
- Adjusted EBITDA is a non-IFRS financial measure. Refer to the Non-IFRS Financial Measures disclosure below for a reconciliation to the nearest IFRS equivalent.
EnWave’s consolidated interim financial statements and MD&A are available on SEDAR+ at www.sedarplus.ca and on the Company’s website www.enwave.net
Key Financial Highlights for the Nine Months Ended Q3 2024 (expressed in 000’s)
- Royalties for the nine months ending June 30, 2024 were $1,319 compared to $1,085 for the same period ending June 30, 2023, an increase of $234 or 22%. Royalties grew due to increased partner product sales and production offset by a decrease in exclusivity fees.
- Reported revenue for Q3 2024 of $4,547, representing a decrease of $5,349 relative to the comparable period in the prior year. The decrease was related to overall fewer machine sales and machines in fabrication compared to the prior period due to the inherent volatility in large-scale Radiant Energy Vacuum (“REV™”) machine orders.
- SG&A costs for the nine months ending June 30, 2024 were $4,016 compared to $4,140 for the same period ending June 30, 2023, a decrease of $124, as a result of concerted efforts to maintain discretionary spending.
- Adjusted EBITDA(1) loss for the nine months ended Q3 2024 of $1,939, compared to an Adjusted EBITDA(1) profit of $703 in the same period in the prior year due to fewer machine sales to absorb fixed overhead costs.
Significant Corporate Accomplishments in Q3 2024 and Subsequently:
- Signed a Technology Evaluation and License Option Agreement with a North American food company led by a renowned chef with multiple Michelin Stars.
- Signed an Equipment Purchase Agreement for a 120kW REV® dehydration machine with an existing royalty partner.
- Signed an Equipment Purchase Agreement with BranchOut Foods LLC, a current royalty partner, for a 100kW REV™ dehydration machine to provide additional drying capacity.
- Signed a Commercial License Agreement with Bounty Specialty Foods to produce several product types in the Philippines and sold a 10kW REV™ dehydration machine for product development.
- Signed a Commercial Licence Agreement with an existing royalty partner to produce several tropical fruit products in an unspecified Central American country. An annual six-figure royalty fee will be paid in exchange for the exclusive rights.
- Subsequent to the quarter, repurchased a large-scale machine from a cannabis multi-state operator to expedite the completion of the 120kW REV™ Branchout Foods LLC Equipment Purchase Agreement.
Mesures financières non conformes aux IFRS :
This news release refers to Adjusted EBITDA which is a non-IFRS financial measure. We define Adjusted EBITDA as earnings before deducting amortization and depreciation, stock-based compensation, foreign exchange gain or loss, finance expense or income, income tax expense or recovery and non-recurring impairment, restructuring and severance charges, and discontinued operations. This measure is not necessarily comparable to similarly titled measures used by other companies and should not be construed as an alternative to net income or cash flow from operating activities as determined in accordance with IFRS. Please refer to the reconciliation between Adjusted EBITDA and the most comparable IFRS financial measure reported in the Company’s consolidated interim financial statements.
Three months ended June 30, | Nine months ended June 30 | |||||
($ ‘000s) | 2024 | 2023 | 2024 | 2023 | ||
Net loss after income tax | (267) | (1,949) | (2,973) | (6,677) | ||
Amortization and depreciation | 299 | 276 | 862 | 841 | ||
Stock-based compensation | 32 | 103 | 218 | 468 | ||
Foreign exchange (gain) loss | (9) | 54 | (36) | 86 | ||
Finance income | (42) | (53) | (148) | (132) | ||
Finance expense | 40 | 31 | 103 | 99 | ||
Non-recurring impairment expense | – | 315 | – | 315 | ||
Discontinued operations | 32 | 1,031 | 35 | 5,703 | ||
Adjusted EBITDA | 85 | (192) | (1,939) | 703 |
Non-IFRS financial measures should be considered together with other data prepared in accordance with IFRS to enable investors to evaluate the Company’s operating results, underlying performance and prospects in a manner similar to EnWave’s management. Accordingly, these non-IFRS financial measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. For more information, please refer to the Non-IFRS Financial Measures section in the Company’s MD&A available on SEDAR+ www.sedarplus.ca.
À propos d'EnWave
EnWave est un leader mondial dans l'innovation et l'application de la déshydratation par micro-ondes sous vide. Depuis son siège à Delta, en Colombie-Britannique, EnWave a développé un solide portefeuille de propriété intellectuelle, perfectionné sa technologie Radiant Energy Vacuum (REV™) et transformé une idée novatrice en une solution de séchage éprouvée, cohérente et évolutive pour les industries alimentaire, pharmaceutique et du cannabis, qui surpasse largement les méthodes de séchage traditionnelles en termes d'efficacité, de capacité, de qualité des produits et de coût.
Avec plus de cinquante partenaires générateurs de redevances répartis dans vingt-trois pays et sur cinq continents, les partenaires licenciés d'EnWave créent des en-cas et des ingrédients rentables et inédits, améliorent la qualité et la régularité de leurs offres existantes, réduisent leurs coûts et accèdent plus rapidement au marché grâce à la technologie brevetée de la société, à ses machines sous licence et à ses conseils d'experts.
La stratégie d'EnWave consiste à signer des licences commerciales assorties de redevances avec les producteurs de denrées alimentaires qui souhaitent sécher mieux, plus rapidement et plus économiquement que la lyophilisation, le séchage sur claies et le séchage à l'air, et profiter des avantages suivants : produire de nouveaux produits intéressants, atteindre des niveaux d'humidité optimaux jusqu'à sept fois plus rapidement, et améliorer le goût, la texture, la couleur et la valeur nutritionnelle des produits.
Pour en savoir plus, consultez le site EnWave.net.
EnWave Corporation
M. Brent Charleton, CFA
Président et directeur général
Pour plus d'informations :
Brent Charleton, CFA, président et directeur général au +1 (778) 378-9616
E-mail : bcharleton@enwave.net
Dylan Murray, CPA, CA, CFO at +1 (778) 870-0729
E-mail : dmurray@enwave.net
Safe Harbour pour les déclarations d'informations prospectives : Ce communiqué de presse peut contenir des informations prospectives basées sur les attentes, les estimations et les projections de la direction. Toutes les déclarations portant sur des attentes ou des projections concernant l'avenir, y compris les déclarations relatives à la stratégie de croissance de la société, au développement de produits, à la position sur le marché, aux dépenses prévues et aux synergies attendues à la suite de la clôture, sont des déclarations prospectives. L'exactitude de toutes les affirmations de tiers mentionnées dans le présent communiqué n'est pas garantie. Toutes les références de tiers à des informations de marché dans ce communiqué ne sont pas garanties comme étant exactes car la société n'a pas effectué la recherche primaire originale. Ces déclarations ne constituent pas une garantie de performance future et impliquent un certain nombre de risques, d'incertitudes et d'hypothèses. Bien que la société ait tenté d'identifier les facteurs importants susceptibles d'entraîner une différence matérielle entre les résultats réels, d'autres facteurs peuvent faire en sorte que les résultats ne soient pas conformes aux prévisions, aux estimations ou aux intentions. Il n'y a aucune garantie que ces déclarations se révèlent exactes, car les résultats réels et les événements futurs pourraient différer sensiblement de ceux prévus dans ces déclarations. En conséquence, les lecteurs ne devraient pas accorder une confiance excessive aux déclarations prévisionnelles.
La Bourse de croissance TSX et son fournisseur de services de réglementation (tel que ce terme est défini dans les politiques de la Bourse de croissance TSX) n'assument aucune responsabilité quant à la pertinence ou à l'exactitude du présent communiqué.